These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 12466185)

  • 1. Squamous metaplasia of the canaliculi associated with 5-fluorouracil: a clinicopathologic case report.
    Agarwal MR; Esmaeli B; Burnstine MA
    Ophthalmology; 2002 Dec; 109(12):2359-61. PubMed ID: 12466185
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Punctal and canalicular stenosis associated with systemic fluorouracil therapy. Report of five cases and review of the literature.
    Brink HM; Beex LV
    Doc Ophthalmol; 1995; 90(1):1-6. PubMed ID: 8549238
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Docetaxel-induced histologic changes in the lacrimal sac and the nasal mucosa.
    Esmaeli B; Burnstine MA; Ahmadi MA; Prieto VG
    Ophthalmic Plast Reconstr Surg; 2003 Jul; 19(4):305-8. PubMed ID: 12878879
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lacrimal canalicular stenosis associated with systemic 5-fluorouacil therapy.
    Prasad S; Kamath GG; Phillips RP
    Acta Ophthalmol Scand; 2000 Feb; 78(1):110-3. PubMed ID: 10726804
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The treatment of punctal and canalicular stenosis in patients on systemic 5-FU.
    Fezza JP; Wesley RE; Klippenstein KA
    Ophthalmic Surg Lasers; 1999 Feb; 30(2):105-8. PubMed ID: 10037204
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sclerosing canaliculitis after 5-fluorouracil breast cancer chemotherapy.
    Lee V; Bentley CR; Olver JM
    Eye (Lond); 1998; 12 ( Pt 3a)():343-9. PubMed ID: 9775228
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Canalicular stenosis secondary to weekly versus every-3-weeks docetaxel in patients with metastatic breast cancer.
    Esmaeli B; Hortobagyi GN; Esteva FJ; Booser D; Ahmadi MA; Rivera E; Arbuckle R; Delpassand E; Guerra L; Valero V
    Ophthalmology; 2002 Jun; 109(6):1188-91. PubMed ID: 12045065
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intraoperatively Observed Lacrimal Obstructive Features and Surgical Outcomes in External Dacryocystorhinostomy.
    Lee MJ; Khwarg SI; Kim IH; Choi JH; Choi YJ; Kim N; Choung HK
    Korean J Ophthalmol; 2017 Oct; 31(5):383-387. PubMed ID: 28913995
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surgical treatment of punctal-canalicular fibrosis from 5-fluorouracil therapy.
    Seiff SR; Shorr N; Adams T
    Cancer; 1985 Oct; 56(8):2148-9. PubMed ID: 4027942
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Canalicular and nasolacrimal duct blockage: an ocular side effect associated with the antineoplastic drug S-1.
    Esmaeli B; Golio D; Lubecki L; Ajani J
    Am J Ophthalmol; 2005 Aug; 140(2):325-7. PubMed ID: 16086962
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Routine histopathologic evaluation of the lacrimal sac during dacryocystorhinostomy: how useful is it?
    Bernardini FP; Moin M; Kersten RC; Reeves D; Kulwin DR
    Ophthalmology; 2002 Jul; 109(7):1214-7; discussion 1217-8. PubMed ID: 12093640
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epiphora in patients receiving systemic 5-fluorouracil therapy.
    Hassan A; Hurwitz JJ; Burkes RL
    Can J Ophthalmol; 1998 Feb; 33(1):14-9. PubMed ID: 9513767
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nasolacrimal Duct Stenosis after Oral Capecitabine Administration.
    Jang Y; Kim N; Lee KW; Choung HK; Khwarg SI
    Korean J Ophthalmol; 2019 Feb; 33(1):95-96. PubMed ID: 30746917
    [No Abstract]   [Full Text] [Related]  

  • 14. Clinically suspected primary acquired nasolacrimal duct obstruction: clinicopathologic review of 150 patients.
    Tucker N; Chow D; Stockl F; Codère F; Burnier M
    Ophthalmology; 1997 Nov; 104(11):1882-6. PubMed ID: 9373121
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Common canalicular obstruction secondary to the use of Herrick lacrimal plugs, requiring endoscopic dacryocystorhinostomy.
    Dolan L; MacEwen CJ; White P
    J Laryngol Otol; 2009 Jan; 123(1):129-30. PubMed ID: 18538044
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Canalicular stenosis secondary to docetaxel (taxotere): a newly recognized side effect.
    Esmaeli B; Valero V; Ahmadi MA; Booser D
    Ophthalmology; 2001 May; 108(5):994-5. PubMed ID: 11320034
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Punctal-canalicular stenosis related to systemic fluorouracil therapy.
    Caravella LP; Burns JA; Zangmeister M
    Arch Ophthalmol; 1981 Feb; 99(2):284-6. PubMed ID: 7469866
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blockage of the lacrimal drainage apparatus as a side effect of docetaxel therapy.
    Esmaeli B; Hidaji L; Adinin RB; Faustina M; Coats C; Arbuckle R; Rivera E; Valero V; Tu SM; Ahmadi MA
    Cancer; 2003 Aug; 98(3):504-7. PubMed ID: 12879466
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blind canalicular marsupialization in complete punctal absence as part of a systematic approach for classification and treatment of lacrimal system obstructions.
    Rumelt S
    Plast Reconstr Surg; 2003 Aug; 112(2):396-403. PubMed ID: 12900596
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Botulinum toxin for palliative treatment of epiphora in a patient with canalicular obstruction.
    Tu AH; Chang EL
    Ophthalmology; 2005 Aug; 112(8):1469-71. PubMed ID: 15953639
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.